BioCentury | Feb 4, 2016
Distillery Therapeutics

Therapeutics: Interleukin-10 (IL-10)

...testing to treat hematologic malignancies and solid tumors. enGene Inc. and Johnson & Johnson have EG-12...
BioCentury | Oct 19, 2015
Company News

enGene, J&J deal

...develop enGene’s EG-12 to treat inflammatory bowel disease (IBD). enGene and Janssen will jointly develop EG-12...
...patients, after which Janssen will have an option to receive exclusive, worldwide rights to develop EG-12...
...enGene’s non-viral vector gene delivery platform to deliver a payload against an additional undisclosed target. EG-12...
BioCentury | Oct 15, 2015
Company News

J&J partners with pair of Canadian companies

...vectors that deliver genes to intestinal cells. The partners will jointly develop lead enGene program EG-12...
...have an option to obtain an exclusive, worldwide license to the therapy in all indications. EG-12...
Items per page:
1 - 3 of 3